AB Science S.A. (LON:0Q77)
London
· Delayed Price · Currency is GBP · Price in EUR 1.440
0.00 (0.00%)
At close: Apr 23, 2025
AB Science Revenue
AB Science had revenue of 560.00K EUR in the half year ending June 30, 2024, a decrease of -10.97%. This brings the company's revenue in the last twelve months to 1.08M, up 39.25% year-over-year. In the year 2023, AB Science had annual revenue of 970.00K with 1.25% growth.
Revenue (ttm)
1.08M EUR
Revenue Growth
+39.25%
P/S Ratio
86.80
Revenue / Employee
18.98K EUR
Employees
57
Market Cap
79.63M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 970.00K | 12.00K | 1.25% |
| Dec 31, 2022 | 958.00K | -649.00K | -40.39% |
| Dec 31, 2021 | 1.61M | 24.00K | 1.52% |
| Dec 31, 2020 | 1.58M | 12.00K | 0.76% |
| Dec 31, 2019 | 1.57M | -130.00K | -7.64% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
AB Science News
- 24 days ago - Dow Erases Earlier Declines - Barron's
- 24 days ago - California introduces Bitcoin rights in amended digital assets bill - Cointelegraph
- 4 months ago - PV, Vajpayee mutual respect priceless: Anurag Thakur - The Times of India